American Well Corporation

American Well Corp. engages in the provision of online healthcare services. It offers a single platform to support all telehealth needs from urgent to acute and post-acute care, chronic care management, and healthy living. Its services include urgent care, behavioral health, breastfeeding support, chronic care, nutrition counseling, pediatrics, telestroke, and virtual primary care. The company was founded by Ido Schoenberg and Roy Schoenberg in June 2006 and is headquartered in Boston, MA.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

AMWL reports Q4 achievements, eyes revenue growth through Converge

AMWL's Q4 performance highlighted achievements in client migrations and strategic partnerships, with a focus on revenue growth for 2023.
Strengths include ACV growth, strong demand for behavioral health solutions, and the potential of the Converge platform to drive integration.
Challenges lie in revenue outlook impacted by customer churn, while opportunities exist in driving growth through Converge and service revenue.
Despite uncertainties, AMWL remains confident in its position in the digital care market and readiness to capitalize on market opportunities.

American Well (AMWL) reports Q1 growth amid margin challenges

AMWL's Q1 performance showed revenue growth but challenges in margins due to operational factors.
The company's focus on customer relationships and solution-based sales strategy are key strengths.
Opportunities lie in leveraging subscription revenue, market receptivity, and a strong financial position for future growth.
Challenges include margin pressures, limited growth avenues without mergers, and market scrutiny on key operational metrics.

American Well (AMWL) excels in Q2 with Converge migrations and international partnerships

AMWL's Q2 performance showcased strong client migrations, new wins, and international partnerships, with a focus on profitability.
Converge's modularity and end-to-end experience drive efficiency and positive renewals, while challenges include managing churn and pricing.
Opportunities in successful client migrations, market shift towards production platforms, and behavioral health integration are key growth areas.
Efforts to simplify the customer journey and accelerate ROI realization through modular approaches are underway for AMWL.

AMWL excels in Q3 with government wins and strategic partnerships

American Well Corporation's Q3 earnings call highlighted strong performance, strategic wins, and operational improvements positioning the company for future growth.
While facing challenges with legacy platforms, AMWL's focus on Converge, cost savings, and client engagement presents opportunities for enhanced profitability.
With a clear roadmap for growth and a focus on customer-centric solutions, AMWL is poised for significant revenue expansion and margin improvement in the coming years.

AMWL reports solid Q4 performance, eyes revenue growth opportunities

AMWL's Q4 performance reflects strategic advancements, high client satisfaction, and revenue diversification, positioning the company for future growth.
While facing challenges in achieving breakeven EBITDA and addressing subscription revenue declines, AMWL's strengths in market traction and sales model transformation offer growth opportunities.
Guidance for 2024 and 2025 outlines a clear path towards revenue growth, improved EBITDA, and leveraging Converge for enhanced customer value and revenue generation.

American Well (AMWL) reports strong Q1 growth and eyes retail expansion

American Well's Q1 performance showcased growth and cost structure improvements, with a focus on subscription revenue.
The company's strategic initiatives target efficiency improvements and higher-margin software subscriptions.
Opportunities lie in market shifts towards complete healthcare solutions and expansion with existing customers.
Challenges include cost initiatives towards profitability and addressing impacts of lower subscription software revenue.

American Well Corp. reports revenue growth and boosts EBITDA guidance

AMWL's Q2 2024 performance reflects positive revenue growth, improved gross profit margin, and adjusted EBITDA guidance raise, underlining the company's progress.
While facing challenges in achieving positive EBITDA and operational efficiency, AMWL's strengths in customer relationships, cost-cutting measures, and market positioning offer strategic advantages.
Opportunities for AMWL include optimizing spend, expanding client base, and leveraging its unique position in the digital healthcare market to drive future growth and profitability.

American Well Corp reports Q3 growth and strategic positioning

American Well Corporation (AMWL) demonstrated steady revenue growth and a commitment to strategic initiatives in Q3 2024.
While facing challenges in achieving profitability, the company's focus on cost alignment and growth positioning bodes well for future performance.
Opportunities in leveraging key contracts and subscription revenue growth position AMWL for continued success in the healthcare technology sector.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

BOSTON, Sept. 21, 2020 /PRNewswire/ -- Amwell®, a national telehealth leader, today announced the closing of its upsized initial public offering of 47,405,555 shares of its Class A common stock at an initial offering price of $18.00 per share, which includes the full exercise of the underwriters' option to purchase 6,183,333 additional shares of Class A common stock from Amwell and certain stockholders of Amwell (the "Selling Stockholders").

Amwell Announces Closing of Upsized Initial Public Offering and Full Exercise of the Underwriters' Option to Purchase Additional Shares

Amwell is a telehealth company which has seen a successful public debut, although slightly less of enthusiastic welcome than other IPO's these days.

Amwell - Healthy Business, Healthy Stock?

The company is coming to market at a hot time for IPOs, and it operates in a segment that is popular with investors.

Google Telehealth Partner Amwell Zooms 28% Higher in First Days of Trading

Amwell: Listen To The CEO Warning

Both the public and private markets are clamoring for telehealth, with venture capitalists investing more than $1.1 billion so far this year, according to PitchBook.

Telehealth Race Kicks Into Gear As Amwell IPO Cashes In On Coronavirus Boom

"It's not a doc in the box in the cloud. It's basically another tool in the tool set of our trusted providers, and that will take years to develop," Amwell co-CEO Ido Schoenberg told CNBC.

Telehealth transformation will still take years despite pandemic boom, says Amwell co-CEO

The Amwell (AMWL) IPO is underway for the telemedicine company based out of Boston and we have a few things to know about it.
The post Amwell IPO: 13 Things for Potential AMWL Stock Investors to Know appeared first on InvestorPlace.

Amwell IPO: 13 Things for Potential AMWL Stock Investors to Know

American Well Corp. AMWL, , known as Amwell, said late Wednesday that its upsized initial public offering priced at $18 a share, above the expected range of between $14 and $16 a share, as the Boston-based telemedicine company raised $742 million.

Amwell raised $742 million as upsized IPO prices above expected range

BOSTON, Sept. 16, 2020 /PRNewswire/ -- Amwell®, a national telehealth leader, today announced the pricing of its upsized initial public offering of 41,222,222 shares of its Class A common stock at an initial public offering price of $18.00 per share for total gross proceeds of.

Amwell Announces Pricing of Upsized Initial Public Offering

Boston-based Amwell has hosted nearly 3 million digital visits in first half of 2020

Google-Backed Telehealth Firm Set to Go Public

Snowflake

Benzinga took a look at high profile IPOs coming in the second half of 2020. Six of those 13 companies could price the week of September 14.

IPO Outlook For The Week: Snowflake and Amwell Lead Busy 12 IPO Lineup

Amwell seeks to raise $525 million in an IPO of its Class A stock.

Amwell Proposes Terms For $525 Million IPO

News for American Well Corporation Stock (AMWL)